DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,027,822 | +0.3% | 12,204 | -3.0% | 0.17% | +4.8% |
| Q2 2023 | $3,018,720 | -4.5% | 12,578 | +0.3% | 0.17% | -9.3% |
| Q1 2023 | $3,159,570 | -21.2% | 12,536 | -17.0% | 0.18% | -25.3% |
| Q4 2022 | $4,010,765 | +3.5% | 15,111 | +0.7% | 0.24% | -7.2% |
| Q3 2022 | $3,875,000 | +18.5% | 15,001 | +16.3% | 0.26% | +26.9% |
| Q2 2022 | $3,270,000 | -23.4% | 12,897 | -11.3% | 0.21% | -11.1% |
| Q1 2022 | $4,267,000 | -6.8% | 14,547 | +4.6% | 0.23% | -1.3% |
| Q4 2021 | $4,577,000 | +7.2% | 13,911 | -0.8% | 0.24% | -0.4% |
| Q3 2021 | $4,269,000 | +15.6% | 14,022 | +1.9% | 0.24% | +15.0% |
| Q2 2021 | $3,692,000 | -1.4% | 13,759 | -17.3% | 0.21% | -7.6% |
| Q1 2021 | $3,743,000 | +0.1% | 16,631 | -1.2% | 0.22% | -7.1% |
| Q4 2020 | $3,739,000 | -4.8% | 16,832 | -7.7% | 0.24% | -15.4% |
| Q3 2020 | $3,927,000 | +1752.4% | 18,239 | +1419.9% | 0.28% | +1681.2% |
| Q2 2020 | $212,000 | -43.3% | 1,200 | -50.7% | 0.02% | -38.5% |
| Q4 2019 | $374,000 | -48.9% | 2,434 | -66.4% | 0.03% | -67.1% |
| Q2 2016 | $732,000 | +223.9% | 7,247 | +152.8% | 0.08% | +276.2% |
| Q2 2014 | $226,000 | – | 2,867 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |